GGrantIndex
Sort

53,477 grants matching addiction

Wireless withdrawal detection and monitoring system for neonatal abstinence syndrome.

$1,284,826
Shiva Sharareh · Rekovar Inc. · R44 · FY2023 · DA

Evaluation Of Treatments Of Opioid And Cocaine Dependence

$1,284,257
Kenzie L Preston · National Institute On Drug Abuse · Z01 · FY2007 · DA

Prevention of Relapse in Addiction

$1,284,257
Kenzie Preston · National Institute On Drug Abuse · Z01 · FY2007 · DA

1/24 Healthy Brain and Child Development National Consortium

$1,284,211
Wei Gao · Cedars-Sinai Medical Center · U01 · FY2022 · DA

Sex and Gender Influences on Addiction and Health: A Developmental Perspective

$1,283,792
Emmalee S. Bandstra · University Of Miami School Of Medicine · P50 · FY2011 · DA

Oncogenic mechanisms and molecular targets in lymphoma

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

RNA interference-based screens for molecular targets in cancer

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Oncogenic mechanisms and molecular targets in myeloma

$1,283,581
Louis Staudt · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Treatment of Chemotherapy-Induced Peripheral Neuropathy via Genetic Repression of Sodium Channels

$1,283,183
Fernando Aleman Guillen · Navega Therapeutics, Inc. · R44 · FY2022 · CA

Technology-based Treatmentsfor Substance Use Disorders

$1,282,410
Lisa A Marsch · Dartmouth College · P30 · FY2016 · DA

Endocannabinoid Active Sites as Therapeutic Targets

$1,281,665
Alexandros Makriyannis · Northeastern University · P01 · FY2014 · DA

Functional and Structural Brain Circuits Underlying Smoking

$1,281,586
Elliot A Stein · National Institute On Drug Abuse · ZIA · FY2012 · DA

Optimizing the use of ketamine to reduce chronic postsurgical pain

$1,281,438
Jing Wang · New York University School Of Medicine · UH3 · FY2021 · CA

Development and Evaluation of Computerized Chemosensory-Based Orbitofrontal Networks Training for Treatment of Pain (CBOT-P)

$1,280,870
Charles Chiedu Nwaokobia · Evon Medics, Llc · R44 · FY2025 · NS

The National Drug Abuse Treatment Clinical Trials Network (U10)

$1,280,852
Roger D. Weiss · Mclean Hospital · U10 · FY2011 · DA

Translational Addiction Sciences Center

$1,280,535
Kathryn A. Cunningham · University Of Texas Med Br Galveston · P50 · FY2015 · DA

Improving the efficacy of anti-nicotine immunotherapy

$1,280,461
Alexey G Mukhin · Duke University · RC2 · FY2010 · DA

Stress and Addiction Neuroscience Unit

$1,279,517
Leandro Vendruscolo · National Institute On Drug Abuse · ZIA · FY2024 · DA

Neurobiology of Addiction Research Center

$1,278,354
Peter W Kalivas · Medical University Of South Carolina · P50 · FY2015 · DA

Neurobiology of Addiction Research Center (NARC)

$1,276,456
Medical University Of South Carolina · P50 · FY2003 · DA

University of Washington Center of Excellence in Opioid Addiction Research

$1,276,358
Charles Chavkin · University Of Washington · P30 · FY2019 · DA

AACAP Physician Scientist Program in Substance Abuse

$1,275,966
Paula Riggs · American Academy-Child/Adolescent Psych · K12 · FY2015 · DA

Cannabidiol for postoperative Opioid Reduction in primary total Knee arthroplasty – a randomized, 2x2 factorial, double-blind, placebo-controlled clinical trial (The CORK trial)

$1,275,381
Chad M Brummett · University Of Michigan At Ann Arbor · U01 · FY2023 · AR

Comparative Risk of Oral Complications Associated with Medications for Opioid Use Disorder: A Mixed-Methods Approach

$1,275,122
Payel Jhoom Roy · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DE

Clinical Trials Network: Pacific Northwest Node

$1,274,771
Mary Akiko Hatch · University Of Washington · UG1 · FY2020 · DA